Last checked at 7 Jul 2014 10:03
Tristel plc
("Tristel" or "the Company")
Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, today announces that 220,000 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") have been issued and allotted pursuant to the exercise of share options by employees.
Application has been made for the 220,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on 11 July 2014. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.
The total number of Ordinary Shares in issue following Admission will be 40,454,701. Accordingly, the figure of 40,454,701 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
Tristel plc | Tel: 01638 721 500 |
Paul Swinney, Chief Executive Officer | |
Liz Dixon, Finance Director | |
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07854 391 303 |
finnCap | Tel: 020 7220 0500 |
Geoff Nash (Corporate Finance) | |
Charlotte Stranner (Corporate Finance) | |
Stephen Norcross (Corporate Broking) |
|